SCHEMBL2893277

SCHEMBL2893277

O=C(O)NC(=S)NCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.72
MITF O75030 1/20 0.72
ALOX12 P18054 5/20 0.70
HPGD P15428 1/20 0.70
MEN1 O00255 2/20 0.68
POLB P06746 2/20 0.68
KMT2A Q03164 2/20 0.68
GAA P10253 2/20 0.68
MAPT P10636 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
LMNA P02545 2/20 0.64
PKM P14618 1/20 0.61
CA12 O43570 1/20 0.60
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
CA9 Q16790 1/20 0.60
MAOA P21397 1/20 0.59
MAOB P27338 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3063087 0.85 ALDH1A1 (0.68) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL14096444 0.84 ALDH1A1 (1.00) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL1275902 0.83 ALOX12 (1.00) ALDH1A1ALOX12HPGDMEN1POLB
SCHEMBL23727605 0.82 ALDH1A1 (0.60) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL3059505 0.81 ALDH1A1 (0.70) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL5458272 0.81 ALDH1A1 (0.75) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL18894145 0.80 ALDH1A1 (0.73) ALDH1A1ALOX12MEN1KMT2AMAPT
SCHEMBL27866 0.79 CYP2D6 (0.80) ALDH1A1ALOX12HPGDMEN1POLB
SCHEMBL5445732 0.79 MMP1 (0.74) ALDH1A1MITFALOX12HPGDMEN1
SCHEMBL14096450 0.79 RAB9A (0.76) ALDH1A1MITFALOX12MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023015156-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION HUDSPETH A JAMES (US) 2023-02-09 WO disclosed
US-8461160-B2 Dihydropyrimidinones HOFFMANN-LA ROCHE, INC. (US) 2013-06-11 US disclosed
WO-2010128058-A1 DIHYDROPYRIMIDINONES FOR USE AS BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO disclosed
US-20100286158-A1 DIHYDROPYRIMIDINONES HOFFMANN-LA ROCHE, INC. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286158-A1 DIHYDROPYRIMIDINONES BACE2, BACE1, PSEN2 ALDH1A1 563/4885MITF 2478/4885ALOX12 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.